SE9502472L - Cyklosporinkomposition baserad på en L2-fas - Google Patents

Cyklosporinkomposition baserad på en L2-fas

Info

Publication number
SE9502472L
SE9502472L SE9502472A SE9502472A SE9502472L SE 9502472 L SE9502472 L SE 9502472L SE 9502472 A SE9502472 A SE 9502472A SE 9502472 A SE9502472 A SE 9502472A SE 9502472 L SE9502472 L SE 9502472L
Authority
SE
Sweden
Prior art keywords
phase
cyclosporine
composition based
specific
biologically active
Prior art date
Application number
SE9502472A
Other languages
English (en)
Swedish (sv)
Other versions
SE9502472D0 (sv
SE504582C2 (sv
Inventor
Kaare Larsson
Helena Ljusberg-Wahren
Original Assignee
Gs Dev Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gs Dev Ab filed Critical Gs Dev Ab
Priority to SE9502472A priority Critical patent/SE504582C2/sv
Publication of SE9502472D0 publication Critical patent/SE9502472D0/xx
Priority to EP96923154A priority patent/EP0873133B1/en
Priority to AT96923154T priority patent/ATE213951T1/de
Priority to PCT/SE1996/000893 priority patent/WO1997002042A1/en
Priority to BR9609332A priority patent/BR9609332A/pt
Priority to CZ9819A priority patent/CZ1998A3/cs
Priority to ES96923154T priority patent/ES2123477T3/es
Priority to DE0873133T priority patent/DE873133T1/de
Priority to CA002226219A priority patent/CA2226219A1/en
Priority to AU63745/96A priority patent/AU6374596A/en
Priority to JP9505078A priority patent/JPH11508592A/ja
Priority to DE69619700T priority patent/DE69619700T2/de
Publication of SE9502472L publication Critical patent/SE9502472L/
Publication of SE504582C2 publication Critical patent/SE504582C2/sv
Priority to NO980032A priority patent/NO980032L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1274—Non-vesicle bilayer structures, e.g. liquid crystals, tubules, cubic phases, cochleates; Sponge phases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A61K38/13—Cyclosporins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
SE9502472A 1995-07-06 1995-07-06 Cyklosporinkomposition baserad på en L2-fas SE504582C2 (sv)

Priority Applications (13)

Application Number Priority Date Filing Date Title
SE9502472A SE504582C2 (sv) 1995-07-06 1995-07-06 Cyklosporinkomposition baserad på en L2-fas
DE69619700T DE69619700T2 (de) 1995-07-06 1996-07-02 Cyclosporin enthaltende, biologisch aktive zubereitung
ES96923154T ES2123477T3 (es) 1995-07-06 1996-07-02 Composicion biologicamente activa que comprende ciclosporina.
CA002226219A CA2226219A1 (en) 1995-07-06 1996-07-02 Biologically active composition comprising cyclosporine
PCT/SE1996/000893 WO1997002042A1 (en) 1995-07-06 1996-07-02 Biologically active composition comprising cyclosporine
BR9609332A BR9609332A (pt) 1995-07-06 1996-07-02 Composição biologicamente ativa processo para a fabricação da mesma e uso de uma fase
CZ9819A CZ1998A3 (cs) 1995-07-06 1996-07-02 Biologicky aktivní přípravek obsahující cyklosporin
EP96923154A EP0873133B1 (en) 1995-07-06 1996-07-02 Biologically active composition comprising cyclosporine
DE0873133T DE873133T1 (de) 1995-07-06 1996-07-02 Cyclosporine enthaltende, biologisch aktive zubereitung
AT96923154T ATE213951T1 (de) 1995-07-06 1996-07-02 Cyclosporin enthaltende, biologisch aktive zubereitung
AU63745/96A AU6374596A (en) 1995-07-06 1996-07-02 Biologically active composition comprising cyclosporine
JP9505078A JPH11508592A (ja) 1995-07-06 1996-07-02 シクロスポリンからなる生物活性組成物
NO980032A NO980032L (no) 1995-07-06 1998-01-05 Biologisk aktiv blanding omfattende cyklosporin

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9502472A SE504582C2 (sv) 1995-07-06 1995-07-06 Cyklosporinkomposition baserad på en L2-fas

Publications (3)

Publication Number Publication Date
SE9502472D0 SE9502472D0 (sv) 1995-07-06
SE9502472L true SE9502472L (sv) 1997-01-07
SE504582C2 SE504582C2 (sv) 1997-03-10

Family

ID=20398887

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9502472A SE504582C2 (sv) 1995-07-06 1995-07-06 Cyklosporinkomposition baserad på en L2-fas

Country Status (12)

Country Link
EP (1) EP0873133B1 ( )
JP (1) JPH11508592A ( )
AT (1) ATE213951T1 ( )
AU (1) AU6374596A ( )
BR (1) BR9609332A ( )
CA (1) CA2226219A1 ( )
CZ (1) CZ1998A3 ( )
DE (2) DE873133T1 ( )
ES (1) ES2123477T3 ( )
NO (1) NO980032L ( )
SE (1) SE504582C2 ( )
WO (1) WO1997002042A1 ( )

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE511313C2 (sv) 1997-01-13 1999-09-06 Gs Dev Ab Komposition med reglerad frisättning innefattande fettsyraester av diacylglycerol
EP1039893B1 (en) 1997-12-10 2011-02-02 Cyclosporine Therapeutics Limited Pharmaceutical compositions containing an omega-3 fatty acid oil
US6638522B1 (en) * 1998-12-11 2003-10-28 Pharmasolutions, Inc. Microemulsion concentrate composition of cyclosporin
ES2289153T7 (es) 2001-11-08 2009-06-18 Atrium Medical Corporation Dispositivo intraluminal con un revestimiento que contiene un agente terapeutico.
US9801982B2 (en) 2004-09-28 2017-10-31 Atrium Medical Corporation Implantable barrier device
US20060088596A1 (en) 2004-09-28 2006-04-27 Atrium Medical Corporation Solubilizing a drug for use in a coating
US9012506B2 (en) 2004-09-28 2015-04-21 Atrium Medical Corporation Cross-linked fatty acid-based biomaterials
US8312836B2 (en) 2004-09-28 2012-11-20 Atrium Medical Corporation Method and apparatus for application of a fresh coating on a medical device
US9000040B2 (en) 2004-09-28 2015-04-07 Atrium Medical Corporation Cross-linked fatty acid-based biomaterials
EP1811935B1 (en) 2004-09-28 2016-03-30 Atrium Medical Corporation Heat cured gel and method of making
US8367099B2 (en) 2004-09-28 2013-02-05 Atrium Medical Corporation Perforated fatty acid films
US9278161B2 (en) 2005-09-28 2016-03-08 Atrium Medical Corporation Tissue-separating fatty acid adhesion barrier
US9427423B2 (en) 2009-03-10 2016-08-30 Atrium Medical Corporation Fatty-acid based particles
AU2006304590A1 (en) 2005-10-15 2007-04-26 Atrium Medical Corporation Hydrophobic cross-linked gels for bioabsorbable drug carrier coatings
EP2626091B1 (en) 2006-11-06 2016-09-28 Atrium Medical Corporation Coated surgical mesh
US9492596B2 (en) 2006-11-06 2016-11-15 Atrium Medical Corporation Barrier layer with underlying medical device and one or more reinforcing support structures
PT2079456E (pt) 2007-04-04 2013-03-13 Sigmoid Pharma Ltd Composições farmacêuticas de ciclosporina
BRPI1012196B1 (pt) 2009-05-18 2021-11-30 Sublimity Therapeutics Limited Composição compreendendo gotas de óleo
US20110038910A1 (en) 2009-08-11 2011-02-17 Atrium Medical Corporation Anti-infective antimicrobial-containing biomaterials
GB2485327A (en) 2009-08-12 2012-05-09 Sigmoid Pharma Ltd Immunomodulatory compositions comprising a polymer matrix and an oil phase
EP2593141B1 (en) 2010-07-16 2018-07-04 Atrium Medical Corporation Composition and methods for altering the rate of hydrolysis of cured oil-based materials
GB201020032D0 (en) 2010-11-25 2011-01-12 Sigmoid Pharma Ltd Composition
JO3337B1 (ar) * 2010-12-13 2019-03-13 Debiopharm Sa تركيبات صيدلية تشمل أليسبوريفير
US9867880B2 (en) 2012-06-13 2018-01-16 Atrium Medical Corporation Cured oil-hydrogel biomaterial compositions for controlled drug delivery
GB201304662D0 (en) 2013-03-14 2013-05-01 Sigmoid Pharma Ltd Compositions
CN107106644B (zh) * 2014-11-07 2022-04-15 卓越治疗有限公司 包含环孢菌素的组合物

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI65914C (fi) * 1978-03-07 1984-08-10 Sandoz Ag Foerfarande foer framstaellning av farmaceutiska kompositionerinnehaollande cyklosporin a
SE457693B (sv) * 1986-07-01 1989-01-23 Drilletten Ab Komposition med reglerad frigoering vari ett biologiskt material aer loest eller dispergerat i en l2-fas
GB9113872D0 (en) * 1991-06-27 1991-08-14 Sandoz Ag Improvements in or relating to organic compounds

Also Published As

Publication number Publication date
DE873133T1 (de) 1999-05-06
EP0873133B1 (en) 2002-03-06
WO1997002042A1 (en) 1997-01-23
NO980032L (no) 1998-03-03
DE69619700T2 (de) 2002-10-24
NO980032D0 (no) 1998-01-05
BR9609332A (pt) 1999-05-25
ES2123477T3 (es) 2002-08-01
ES2123477T1 (es) 1999-01-16
EP0873133A1 (en) 1998-10-28
SE9502472D0 (sv) 1995-07-06
SE504582C2 (sv) 1997-03-10
JPH11508592A (ja) 1999-07-27
CA2226219A1 (en) 1997-01-23
ATE213951T1 (de) 2002-03-15
AU6374596A (en) 1997-02-05
CZ1998A3 (cs) 1998-06-17
DE69619700D1 (de) 2002-04-11

Similar Documents

Publication Publication Date Title
SE9502472L (sv) Cyklosporinkomposition baserad på en L2-fas
ES2088160T3 (es) Formulacion y proceso quimicos.
CA2221096A1 (en) Skin permeation enhancer compositions comprising glycerol monolaurate and lauryl acetate
NO20005431D0 (no) Gelérbare farmasøytiske preparater
IS4675A (is) Örþeytur til að nota sem burðarefni við inngjöf virkra efna
SE8007639L (sv) Nya tabletter for upplosning i tjocktarmen samt sett for framstellning derav
DK0737065T3 (da) Fremgangsmåde til fremstilling af faste farmaceutiske doseringsformer
EP0983994A3 (de) Dimethyl-(3-aryl-but-3-enyl)-aminverbindungen als pharmazeutische Wirkstoffe
FI884291A (fi) Menetelmä biologisesti aktiivisen proteiinipitoisen aineen valmistamiseksi
IE870800L (en) Dual phase solvent carrier.
IL122401A0 (en) Anti-inflammatory compositions
NO20035434D0 (no) Behandling eller profylakse av transplantasjonsavst degree tning av insulinproduserende celler
CA2384448A1 (en) Method of treatment of seborrheic dermatitis
EP0255028A3 (de) Neue 1,4-Benzodiazepine, ihre Herstellung und Verwendung als PAF Antagonisten
NO992098L (no) Preparat med regulert avgivelse av aktiv forbindelse
YU49113B (sh) Postupak za dobijanje klavulanat soli
IE37250L (en) Triazolobenzodiazepines
IE802033L (en) Dibenzazepine derivatives
IE36563L (en) Triazolo benzodiazepines
IE802606L (en) Pharmaceutical composition
EA200100366A1 (ru) Антагонист хемокинового рецептора и циклоспорин в комбинированной терапии
JPS5354866A (en) Method of treating sewege
Junod The metabolic activity of pulmonary endothelial cells
Mori et al. Histochemical detection of three dehydrogenase systems in ameloblastoma
JPS5557510A (en) Preparation of improved oil foundation

Legal Events

Date Code Title Description
NUG Patent has lapsed